mardi 25 avril 2017

Onco Actu du 25 avril 2017

2.7 Etiologie - Obésité

Kidney cancer rates are increasing, so what’s fuelling the surge? [Cancer Research UK]

4.1 Dép., diag. & prono. - Prostate

Should prostate cancer screening be different for black men? [Fred Hutch]

Prostate Cancer Screening Rates Appear to Level after Recent Drop [ACS]

4.2 Dép., diag. & prono. - Génome

Aggressiveness of breast cancer associated with longer lead times to metastasis [VHIO]

Billionaire Doctor’s $11,000 Cancer Test Has Few Takers So Far [Bloomberg]

5. Traitements

Old blood pressure drug inhibits skin cancer in mice [FierceBiotech]

PARP Inhibitors May Be Effective in Brain, Other Cancers with IDH Mutations [NCI]

5.10 Traitements - Essais

Brexit and the regulation of clinical trials [BMJ Blogs]

5.12 Immunothérapies

Implanted scaffold with T cells rapidly shrinks tumors [Fred Hutch]

5.12.1 Immunothérapies - partenariats

Transgene and Bristol-Myers Squibb Announce Clinical Research Collaboration to Evaluate TG4010 in Combination with Opdivo and Standard Chemotherapy in First Line Non-Small Cell Lung Cancer [BMS]

5.2 Pharma

Lilly's cancer med abemaciclib hits survival mark, but can it stand up to Ibrance and Kisqali? [FiercePharma]

Lilly Announces Phase 3 MONARCH 3 Breast Cancer Study of Abemaciclib Demonstrated Superior Progression-Free Survival at Interim Analysis [Lilly]

Best in class? Eli Lilly claims a lead role awaits its CDK 4/6 drug abemaciclib after PhIII success [EndPoints]

Lilly reports positive interim data on breast cancer combo drug [Reuters]

5.2.3 Pharma - économie

OncoMed Slashes Workforce After Two Clinical Trial Failures in Cancer [Xconomy]

6.1 Observation

A third of emergency cancer patients have not seen their GP [Cancer Research UK]

Cancer patients diagnosed in A&E after being repeatedly rejected by their GPs, research warns [The Telegraph]

Cancer symptoms often missed by GPs in England, study suggests [The Guardian]

6.10.1 Politiques (USA)

Congress is back in session, and sneaking the cruel sham that is right-to-try in a must-pass bill Is on the agenda [Respectful Insolence]

6.12 Ethique

Why The Movie About Henrietta Lacks Matters Today [Forbes]

6.7 DMP, Big Data & applis

Is Reidentifiability a Risk? [Mark Daly - Medium]